ghk cu topical vs oral GHK-Cu Scalp Solution GHK-Cu Rx Protocol
Description
The peptide was shown to counteract the negative effects of methylprednisolone [9, 10]

The effect on radio-resistance of manganese superoxide dismutase in nasopharyngeal carcinoma
Jan 19 2021;16(1):12
They are unapproved compounded products, prepared by compounding pharmacies, which have not been reviewed by the FDA for safety, efficacy or quality in this indication

Tendon and bone models : Research has looked at fibroblast behaviour and the expression of repair-associated growth factors in tendon and bone studies, where the peptide has been associated with improved cell migration and tissue organisation in vitro

BPC-157 does not have approval for any medical use in the United States, which means it has not met FDA standards for safety, effectiveness, and quality